Sep 1, 2026 09:07AM
Aug 26, 2026 08:32PM
Aug 16, 2026 08:35PM
Aug 16, 2026 08:35PM
Jul 29, 2026 08:57PM
Jul 13, 2026 08:35PM
Jul 13, 2026 08:35PM Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
Jul 9, 2026 08:30PM
Jun 30, 2026 08:38PM
Jun 25, 2026 03:26AM
Jun 24, 2026 08:59PM
Apr 28, 2026 08:53PM
Apr 28, 2026 08:53PM
Apr 14, 2026 08:11PM Mesoblast acquires CAR platform technology to enhance cell therapies
Apr 14, 2026 08:10PM
Apr 10, 2026 04:10PM
Apr 10, 2026 04:09PM
Apr 8, 2026 09:07AM
Apr 7, 2026 11:35PM
Mar 18, 2026 11:30AM
Mar 17, 2026 07:19PM Mesoblast to Host R&D Day on April 8, 2026
Mar 11, 2026 07:21PM
Feb 26, 2026 07:42PM
Feb 11, 2026 06:27PM
Jan 28, 2026 06:54PM
Jan 26, 2026 06:45PM
Jan 18, 2026 07:01PM
Jan 8, 2026 06:46PM Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Jan 1, 2026 06:02PM
Jan 1, 2026 06:02PM
Dec 29, 2025 06:57PM
Dec 21, 2025 04:00AM
Dec 11, 2025 06:22PM
Dec 3, 2025 06:10PM
Nov 24, 2025 06:39PM Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue
Nov 20, 2025 06:32PM
Nov 4, 2025 06:40PM
Oct 19, 2025 07:48PM
Oct 6, 2025 07:24PM
Oct 2, 2025 09:04PM
Sep 26, 2025 01:49AM
Sep 14, 2025 09:18PM Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
Sep 3, 2025 09:47PM
Aug 28, 2025 08:24PM
Jul 17, 2025 08:38PM
Jun 30, 2025 08:36PM
Jun 11, 2025 09:24PM
May 14, 2025 11:36PM
May 14, 2025 10:57PM FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
Apr 29, 2025 08:53PM

330,182 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All